Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173022 |
| TEVA-FENTANYL | 100MCG | PATCH | Resolved | 2022-10-28 | 2022-12-02 | 173025 |
| TEVA-FENTANYL | 12MCG | PATCH | Resolved | 2023-01-12 | 2023-06-09 | 180909 |
| TEVA-FENTANYL | 50MCG | PATCH | Resolved | 2023-08-17 | 2023-10-04 | 202265 |
| TEVA-FENTANYL | 100MCG | PATCH | Actual shortage | 2024-01-25 | 2024-04-25 | 217223 |
| TEVA-FENTANYL | 25MCG | PATCH | Actual shortage | 2024-02-01 | 2024-04-25 | 218132 |
| TEVA-FENTANYL | 25MCG | PATCH | Resolved | 2024-02-01 | 2024-02-01 | 218134 |
| TEVA-FENTANYL | 50MCG | PATCH | Actual shortage | 2024-02-01 | 2024-04-25 | 218137 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2017-08-21 | 2017-10-10 | 19944 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2020-05-01 | 2020-05-29 | 113785 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146459 |
| TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2023-02-09 | 2023-04-28 | 184210 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2021-09-23 | 2021-11-25 | 146128 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Resolved | 2021-12-02 | 2022-05-05 | 150406 |
| TEVA-FINGOLIMOD | 0.5MG | CAPSULE | Actual shortage | 2023-07-12 | 2024-02-01 | 198394 |
| TEVA-FLUCONAZOLE | 100MG | TABLET | Actual shortage | 2017-08-01 | 2018-12-21 | 17893 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2017-08-21 | 2017-11-06 | 19947 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2017-08-21 | 2017-11-06 | 19950 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2020-01-24 | 2020-02-13 | 104371 |
| TEVA-FLUOXETINE | 20MG | CAPSULE | Resolved | 2020-01-30 | 2020-02-13 | 104887 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
| TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
| TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
| TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81371 |
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |
| TEVA-LAMOTRIGINE | 25MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81388 |